Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original Article

Adipose Tissue Exosome-Like Vesicles Mediate Activation of Macrophage-Induced Insulin Resistance

  1. Zhong-bin Deng1,
  2. Anton Poliakov2,
  3. Robert W. Hardy3,
  4. Ronald Clements4,
  5. Cunren Liu1,
  6. Yuelong Liu1,
  7. Jianhua Wang1,
  8. Xiaoyu Xiang1,
  9. Shuangqin Zhang1,
  10. Xiaoying Zhuang1,
  11. Spandan V. Shah1,
  12. Dongmei Sun1,
  13. Sue Michalek5,
  14. William E. Grizzle3,
  15. Timothy Garvey4,
  16. Jim Mobley2 and
  17. Huang-Ge Zhang1,6
  1. 1Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama;
  2. 2Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama;
  3. 3Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Albama;
  4. 4Department of Nutrition, University of Alabama at Birmingham, Birmingham, Alabama;
  5. 5Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama;
  6. 6Birmingham Veterans Administration Medical Center, Birmingham, Alabama.
  1. Corresponding author: Huang-Ge Zhang, huang-ge.zhang{at}ccc.uab.edu.
Diabetes 2009 Nov; 58(11): 2498-2505. https://doi.org/10.2337/db09-0216
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Adipose obELVs activate macrophages. A: Wild-type B6 mice fed an HFD for 3 months starting at 2 months of age were injected intravenously with the PKH67+-labeled obELVs or wtELVs (30 μg/mouse). Twenty-four hours after the injection, CD11b+F4/80+PKH67+ cells from peripheral blood were analyzed for the presence of CD204, ICAM-1, and MHCII markers. Results were pooled from five independent experiments (n = 5 mice/experiment) and are presented as the means ± SE, *P < 0.05, **P < 0.01. B: Mice treated as described above at day 1 and 7, peripheral blood was collected at 4 h after the ELV injections, and the serum concentration of IL-6 and TNF-α were determined using a standard ELISA, *P < 0.05, **P < 0.01 (n = 5 mice per group). i.v., intravenous.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Adipose obELVs promote the differentiation and proliferation of BMDMs and impair activation of the insulin signaling pathway in vitro and macrophage infiltration into adipose tissues in vivo. C2C12 cells at 80% confluency were cultured for 24 h in the presence of conditioned medium harvested from 14-day cultures of bone marrow cells that had been pretreated with obELVs, wtELVs, or thymus exosomes (10 μg/ml) at day 0 of the culture and cultured in the presence or absence of GM-CSF. After a 3-h starvation, the C2C12 cells were stimulated with insulin (100 nmol/l) for 20 min and either lysed for Western blot analysis of phosphorylated Akt (A) or used for glucose uptake testing (B). Results presented are representative of a minimum of three experiments (A) or data are the means ± SE of three experiments with two replicates of each (B). *P < 0.05; **P < 0.01. C: B6 mice fed an HFD were intravenously injected with a mixture (1:1) of 4 × 106 of BMDMsPKH26+ that had been preincubated with obELVs with BMDMsPKH67+ that had been preincubated with wtELVs. The percentage of injected macrophages infiltrating adipose tissue, liver, spleen, and bone marrow were determined by FACS analysis of PKH67 and PKH26 14 days after the injection. D: The PKH67+ or PKH26+ cells were gated and analyzed for CD11b+F4/80+. The proliferation of injected fluorescent dye–labeled CD11b+F4/80+ macrophages was then determined by FACS analysis of BrdU+ cells in the adipose tissue, liver, spleen, and bone marrow. A representative graph of FACS analysis of macrophage infiltration in adipose tissue is shown and the data represent the means ± SE from five mice from each group. **P < 0.01. BM, bone marrow.

  • FIG. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    The TLR4/TRIF pathway plays a role in adipose obELV-mediated macrophage activation and the impairment of the insulin response. A: BMDMs from wild-type B6, TLR2 knockout, or TLR4 knockout mice were treated with obELVs (10 μg/ml), and the quantity of IL-6 and TNF-α in 24 h culture supernatants was measured using a standard ELISA. B: BMDMs from wild-type B6, MyD88, or TRIF mice were treated with obELVs (10 μg/ml) at 0 h of the culture, and the quantity of IL-6 and TNF-α in the 24 h culture supernatants was determined as done in Fig. 3A, **P < 0.01. C: The C2C12 cells were cultured for 24 h in the presence of conditioned medium harvested at 24 h after addition of obELV (10 μg/ml) to BMDMs from TLR4 knockout B6 mice or wild-type B6 mice. Glucose uptake experiments were conducted as described in Fig. 2B, *P < 0.05, **P < 0.01. Data are the means ± SE of three experiments with two replicates (A–C). KO, knockout.

  • FIG. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    ObELV RBP4 induces the production of macrophage proinflammatory cytokines via activation of the TLR4/TRIF pathway. A: Fifty micrograms of obELVs and wtELVs were lysed in protein lysis buffer, and each lysate was resolved by PAGE in a 10% SDS gel for Western blot analysis. The signal intensity of each protein was quantified using an Odyssey infrared imaging system (LI-COR). The ratios of signal intensity of each protein in obELVs:wtELVs were calculated and plotted (bar graphs). The data are presented as means of three independent experiments. B: BMDMs from wild-type B6 mice or B6 mice with different gene knockouts were treated with 5 μg/ml of the RBP4. The quantity of IL-6 and TNF-α produced was determined from the supernatants of 24-h cultures. The results represent the means ± SE of triplicate cultures. C: BMDMs from wild-type B6 mice were treated with a mouse RBP4 (5 μg/ml) or dialyzed solution as a control for 24 h. Cells were washed with PBS three times and cultured in the presence of obELVs (10 μg/ml) for an additional 24 h. The supernatants were harvested and IL-6 and TNF-α quantified by ELISA. Data represent the means ± SE of five replicate wells, *P < 0.05, **P < 0.01.

  • FIG. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Injection of obELVs leads to the intolerance of glucose uptake, insulin resistance, and induction of inflammatory cytokines of mice. A and B: Wild-type B6 mice or TLR4 knockout of B6 mice (n = 10) were injected intravenously with obELVs or wtELVs (30 μg/mouse in 200 μl of PBS) every 3 days for 21 days. One day after the last injection (day 22), mice were fasted either overnight before receiving an intraperitoneal injection of 2 mg of dextrose/g body wt for glucose tolerance testing (A) or fasted for 4 h before receiving recombinant human insulin (1 unit/kg i.p.) for insulin responsiveness testing (B). Blood samples were taken at the indicated times (n = 10). Data are means ± SE, *P < 0.05, **P < 0.01. In addition, serum TNF-α and IL-6 was also quantified using a standard ELISA at 4 h after the last injection (C). Data are means ± SE, **P < 0.01. KO, knockout.

PreviousNext
Back to top

In this Issue

November 2009, 58(11)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Adipose Tissue Exosome-Like Vesicles Mediate Activation of Macrophage-Induced Insulin Resistance
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Adipose Tissue Exosome-Like Vesicles Mediate Activation of Macrophage-Induced Insulin Resistance
Zhong-bin Deng, Anton Poliakov, Robert W. Hardy, Ronald Clements, Cunren Liu, Yuelong Liu, Jianhua Wang, Xiaoyu Xiang, Shuangqin Zhang, Xiaoying Zhuang, Spandan V. Shah, Dongmei Sun, Sue Michalek, William E. Grizzle, Timothy Garvey, Jim Mobley, Huang-Ge Zhang
Diabetes Nov 2009, 58 (11) 2498-2505; DOI: 10.2337/db09-0216

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Adipose Tissue Exosome-Like Vesicles Mediate Activation of Macrophage-Induced Insulin Resistance
Zhong-bin Deng, Anton Poliakov, Robert W. Hardy, Ronald Clements, Cunren Liu, Yuelong Liu, Jianhua Wang, Xiaoyu Xiang, Shuangqin Zhang, Xiaoying Zhuang, Spandan V. Shah, Dongmei Sun, Sue Michalek, William E. Grizzle, Timothy Garvey, Jim Mobley, Huang-Ge Zhang
Diabetes Nov 2009, 58 (11) 2498-2505; DOI: 10.2337/db09-0216
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Original Article

  • An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes
  • Loss of Prohibitin Induces Mitochondrial Damages Altering β-Cell Function and Survival and Is Responsible for Gradual Diabetes Development
  • Cbl-b Is a Critical Regulator of Macrophage Activation Associated With Obesity-Induced Insulin Resistance in Mice
Show more Original Article

Metabolism

  • Ncor2/PPARα-Dependent Upregulation of MCUb in the Type 2 Diabetic Heart Impacts Cardiac Metabolic Flexibility and Function
  • Role of the Neutral Amino Acid Transporter SLC7A10 in Adipocyte Lipid Storage, Obesity, and Insulin Resistance
  • Heme Oxygenase-1 Regulates Ferrous Iron and Foxo1 in Control of Hepatic Gluconeogenesis
Show more Metabolism

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.